Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of Bardoxolone Methyl in Alport Syndrome.
Warady BA, Pergola PE, Agarwal R, Andreoli S, Appel GB, Bangalore S, Block GA, Chapman AB, Chin MP, Gibson KL, Goldsberry A, Iijima K, Inker LA, Kashtan CE, Knebelmann B, Mariani LH, Meyer CJ, Nozu K, O'Grady M, Rheault MN, Silva AL, Stenvinkel P, Torra R, Chertow GM. Warady BA, et al. Among authors: inker la. Clin J Am Soc Nephrol. 2022 Dec;17(12):1763-1774. doi: 10.2215/CJN.02400222. Epub 2022 Nov 21. Clin J Am Soc Nephrol. 2022. PMID: 36411058 Free PMC article. Clinical Trial.
Intensive BP Control in Patients with CKD and Risk for Adverse Outcomes.
Ku E, McCulloch CE, Inker LA, Tighiouart H, Schaefer F, Wühl E, Ruggenenti P, Remuzzi G, Grimes BA, Sarnak MJ. Ku E, et al. Among authors: inker la. J Am Soc Nephrol. 2023 Mar 1;34(3):385-393. doi: 10.1681/ASN.0000000000000072. Epub 2023 Jan 17. J Am Soc Nephrol. 2023. PMID: 36735510 Free PMC article.
Cystatin C versus creatinine in determining risk based on kidney function.
Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium. Shlipak MG, et al. Among authors: inker la. N Engl J Med. 2013 Sep 5;369(10):932-43. doi: 10.1056/NEJMoa1214234. N Engl J Med. 2013. PMID: 24004120 Free PMC article.
Association of Integrated Proteomic and Metabolomic Modules with Risk of Kidney Disease Progression.
Schlosser P, Surapaneni AL, Borisov O, Schmidt IM, Zhou L, Anderson A, Deo R, Dubin R, Ganz P, He J, Kimmel PL, Li H, Nelson RG, Porter AC, Rahman M, Rincon-Choles H, Shah V, Unruh ML, Vasan RS, Zheng Z, Feldman HI, Waikar SS, Köttgen A, Rhee EP, Coresh J, Grams ME; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators and the CKD Biomarkers Consortium. Schlosser P, et al. J Am Soc Nephrol. 2024 Apr 19. doi: 10.1681/ASN.0000000000000343. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 38640019 No abstract available.
Dihydropyridine Calcium Channel Blockers and Kidney Outcomes.
Blum MF, Surapaneni A, Chang A, Inker LA, Chen TK, Appel LJ, Shin JI, Grams ME. Blum MF, et al. Among authors: inker la. J Gen Intern Med. 2024 Apr 19. doi: 10.1007/s11606-024-08762-2. Online ahead of print. J Gen Intern Med. 2024. PMID: 38639831
Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial.
Heerspink HJL, Stack AG, Terkeltaub R, Jongs N, Inker LA, Bjursell M, Maklad N, Perl S, Eklund O, Rikte T, Sjöström CD, Perkovic V; SAPPHIRE Investigators. Heerspink HJL, et al. Among authors: inker la. J Am Soc Nephrol. 2024 May 1;35(5):594-606. doi: 10.1681/ASN.0000000000000326. Epub 2024 Feb 20. J Am Soc Nephrol. 2024. PMID: 38564654 Clinical Trial. No abstract available.
Glomerular Filtration Rate Estimation Using β2-Microglobulin and β-Trace Protein in Adults With Solid Tumors: A Prospective Cross-Sectional Study.
Costa E Silva VT, Gil LA Jr, Inker LA, Caires RA, Costalonga E, Coura-Filho G, Sapienza MT, Castro G Jr, Estevez-Diz MDP, Zanetta DMT, Antonângelo L, Marçal L, Tighiouart H, Miao S, Mathew P, Levey AS, Burdmann EA. Costa E Silva VT, et al. Among authors: inker la. Am J Kidney Dis. 2024 Mar 26:S0272-6386(24)00684-X. doi: 10.1053/j.ajkd.2024.01.532. Online ahead of print. Am J Kidney Dis. 2024. PMID: 38537905
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.
Levin A, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, Herrington WG, Hill G, Inker LA, Kazancıoğlu R, Lamb E, Lin P, Madero M, McIntyre N, Morrow K, Roberts G, Sabanayagam D, Schaeffner E, Shlipak M, Shroff R, Tangri N, Thanachayanont T, Ulasi I, Wong G, Yang CW, Zhang L, Robinson KA, Wilson L, Wilson RF, Kasiske BL, Cheung M, Earley A, Stevens PE. Levin A, et al. Among authors: inker la. Kidney Int. 2024 Apr;105(4):684-701. doi: 10.1016/j.kint.2023.10.016. Kidney Int. 2024. PMID: 38519239 Free article.
271 results